FDA Inspection
Inotiv, Inc.Inotiv, Inc. – FDA Inspection, May 23, 2025
Record Details
This FDA Inspection record concerns Inotiv, Inc., with an inspection on May 23, 2025, issued by the Detroit District Office, covering human drugs.
View Company Profile
ID · 7185e57a-6c74-46e2-90d5-777d1678277a
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1270617
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring: Human Drugs
FDA Citations
5- 21 CFR 58.130(c)Conduct: identification of test specimens
- 21 CFR 58.185(a)(9)Final report: circumstances affecting data qual., integrity
- 21 CFR 58.33(f)Study director: transfer of data to archives
- 21 CFR 58.35(b)(1)QAU: maintain a master schedule
- 21 CFR 58.35(b)(7)QAU: signed statement in final report
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Inotiv, Inc.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| August 3, 2018 | VAI | Detroit District Office | Bioresearch Monitoring |
Other documents for Inotiv, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.